Montana Chemical Dependency Ctr is a licensed substance use treatment provider in Butte, MT, listed in the SAMHSA treatment directory. It offers hospital inpatient care with medical staff on site around the clock. Clients can live on site in a residential program while they complete treatment. On site detox services are available, so withdrawal can be managed before treatment begins. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Buprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationMethamphetamines detoxificationOpioids detoxificationMedication routinely used during detoxification
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState department of health
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
60 South Last Chance Gulch Street, Helena, MT 59601
OutpatientIntensive outpatient treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
OutpatientResidential/24-hour residentialOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds